Industry Innovation Program (I²)
“Genome British Columbia”
$1,000,000.00
Maximum Eligible Amount
Repayable Contribution
Fund Type
The Industry Innovation Program (I²) provides commercialization support for companies developing innovative life science technologies in British Columbia (BC). Life sciences includes the biological aspects of industry challenges in the key economic sectors of Agrifood, Energy, Mining, Environment, Fisheries and Aquaculture, Forestry, and Health. The I² Program also supports digital health and other technologies that will further move the concept of precision medicine into clinical practice.
The amount of funding allocated by I² ranges from $100,000 to $1,000,000 per company, and is targeted to initiatives where a clear pathway to commercialization can be demonstrated. We will work with companies to help establish this pathway and link them to other stakeholders in the industry. Our early stage capital can take the form of debt, equity and royalties. We help companies establish near term milestones and a portion of funding may be tied to successful execution of these milestones and advanced in tranches. I² funds are repayable with repayments commencing no more than four years after disbursement.
Log in with Google